Advocacy at a Glance STEVEN GROSSMAN 11/18/22 Advocacy at a Glance STEVEN GROSSMAN 11/18/22 2022 Election Results and Committee Leadership; CR Expectations Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/22 Advocacy at a Glance STEVEN GROSSMAN 11/11/22 Election Status Update; Alliance Webinar on Drug Supply Shortages Read More Advocacy at a Glance STEVEN GROSSMAN 11/4/22 Advocacy at a Glance STEVEN GROSSMAN 11/4/22 Patience with Election Results; Congressional Committee Leadership; New Alliance Drug Shortage Webinar Read More Advocacy at a Glance STEVEN GROSSMAN 10/28/22 Advocacy at a Glance STEVEN GROSSMAN 10/28/22 Steven Solomon’s Retirement; Communications on Foodborne Illness Read More Advocacy at a Glance STEVEN GROSSMAN 10/14/22 Advocacy at a Glance STEVEN GROSSMAN 10/14/22 Preparing for 118th Congress; FDA’s New Food Safety Strategies Read More Advocacy at a Glance STEVEN GROSSMAN 10/7/22 Advocacy at a Glance STEVEN GROSSMAN 10/7/22 Congress in Recess; Reagan-Udall Review testimony; and Digital Health and Cyber Security Webinar Read More Advocacy at a Glance STEVEN GROSSMAN 9/30/22 Advocacy at a Glance STEVEN GROSSMAN 9/30/22 CR and User Fees Passed; New OTAT name; Upcoming Webinars Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/22 Advocacy at a Glance STEVEN GROSSMAN 9/23/22 CR and User Fees Next Week; Alliance participating in Reagan-Udall Review; ARPA-H Director Announced Read More Advocacy at a Glance STEVEN GROSSMAN 9/16/22 Advocacy at a Glance STEVEN GROSSMAN 9/16/22 FY 23 CR for Sept 19; Preview for next year appropriations; Webinar with FDA One Health Read More Advocacy at a Glance STEVEN GROSSMAN 9/9/22 Advocacy at a Glance STEVEN GROSSMAN 9/9/22 CR Likely for rest of FY22; User Fee Reauthorization More Hopeful Read More Advocacy at a Glance STEVEN GROSSMAN 9/2/22 Advocacy at a Glance STEVEN GROSSMAN 9/2/22 FY23 CR; No Change to User Fees; FDA Human Food Programs Review Panel Members Read More Advocacy at a Glance STEVEN GROSSMAN 8/19/22 Advocacy at a Glance STEVEN GROSSMAN 8/19/22 FY23 Appropriations Continuing Resolution; User Fee Status Unchanged Read More Advocacy at a Glance STEVEN GROSSMAN 8/12/22 Advocacy at a Glance STEVEN GROSSMAN 8/12/22 August Recess; User Fees Uncertain; Transcript of Dr. Woodcock Webinar Read More Advocacy at a Glance STEVEN GROSSMAN 8/5/22 Advocacy at a Glance STEVEN GROSSMAN 8/5/22 FY23 Appropriations; User fees; Dr. Woodcock on User Fees and Future of FDA Knowledge Management Read More Advocacy at a Glance STEVEN GROSSMAN 7/29/22 Advocacy at a Glance STEVEN GROSSMAN 7/29/22 FY 23 Appropriations Update; User-fee Lay-off Risk; Woodcock Webinar Announcement Read More Advocacy at a Glance STEVEN GROSSMAN 7/22/22 Advocacy at a Glance STEVEN GROSSMAN 7/22/22 Woodcock Webinar; FY23 Appropriations Minibus; and FDA Food Safety Programs face Congress and Independent Review Read More Advocacy at a Glance STEVEN GROSSMAN 7/15/22 Advocacy at a Glance STEVEN GROSSMAN 7/15/22 Ag/FDA FY23 Approps Update, User Fee Reauthorization Uncertainty, and Dr. Woodcock Webinar Announcement Read More Advocacy at a Glance STEVEN GROSSMAN 7/8/22 Advocacy at a Glance STEVEN GROSSMAN 7/8/22 House and Senate Calendar Updates; Understaffed FDA Offices; Inspections Updates Read More Advocacy at a Glance Lisa Ellington 6/24/22 Advocacy at a Glance Lisa Ellington 6/24/22 Commissioner Califf to Address Alliance for a Stronger FDA: July 12 from 1:30 to 2:30. Read More Advocacy at a Glance Lisa Ellington 6/17/22 Advocacy at a Glance Lisa Ellington 6/17/22 House Subcommittee Includes 10% Increase For FDA Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 11/18/22 Advocacy at a Glance STEVEN GROSSMAN 11/18/22 2022 Election Results and Committee Leadership; CR Expectations Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/22 Advocacy at a Glance STEVEN GROSSMAN 11/11/22 Election Status Update; Alliance Webinar on Drug Supply Shortages Read More
Advocacy at a Glance STEVEN GROSSMAN 11/4/22 Advocacy at a Glance STEVEN GROSSMAN 11/4/22 Patience with Election Results; Congressional Committee Leadership; New Alliance Drug Shortage Webinar Read More
Advocacy at a Glance STEVEN GROSSMAN 10/28/22 Advocacy at a Glance STEVEN GROSSMAN 10/28/22 Steven Solomon’s Retirement; Communications on Foodborne Illness Read More
Advocacy at a Glance STEVEN GROSSMAN 10/14/22 Advocacy at a Glance STEVEN GROSSMAN 10/14/22 Preparing for 118th Congress; FDA’s New Food Safety Strategies Read More
Advocacy at a Glance STEVEN GROSSMAN 10/7/22 Advocacy at a Glance STEVEN GROSSMAN 10/7/22 Congress in Recess; Reagan-Udall Review testimony; and Digital Health and Cyber Security Webinar Read More
Advocacy at a Glance STEVEN GROSSMAN 9/30/22 Advocacy at a Glance STEVEN GROSSMAN 9/30/22 CR and User Fees Passed; New OTAT name; Upcoming Webinars Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/22 Advocacy at a Glance STEVEN GROSSMAN 9/23/22 CR and User Fees Next Week; Alliance participating in Reagan-Udall Review; ARPA-H Director Announced Read More
Advocacy at a Glance STEVEN GROSSMAN 9/16/22 Advocacy at a Glance STEVEN GROSSMAN 9/16/22 FY 23 CR for Sept 19; Preview for next year appropriations; Webinar with FDA One Health Read More
Advocacy at a Glance STEVEN GROSSMAN 9/9/22 Advocacy at a Glance STEVEN GROSSMAN 9/9/22 CR Likely for rest of FY22; User Fee Reauthorization More Hopeful Read More
Advocacy at a Glance STEVEN GROSSMAN 9/2/22 Advocacy at a Glance STEVEN GROSSMAN 9/2/22 FY23 CR; No Change to User Fees; FDA Human Food Programs Review Panel Members Read More
Advocacy at a Glance STEVEN GROSSMAN 8/19/22 Advocacy at a Glance STEVEN GROSSMAN 8/19/22 FY23 Appropriations Continuing Resolution; User Fee Status Unchanged Read More
Advocacy at a Glance STEVEN GROSSMAN 8/12/22 Advocacy at a Glance STEVEN GROSSMAN 8/12/22 August Recess; User Fees Uncertain; Transcript of Dr. Woodcock Webinar Read More
Advocacy at a Glance STEVEN GROSSMAN 8/5/22 Advocacy at a Glance STEVEN GROSSMAN 8/5/22 FY23 Appropriations; User fees; Dr. Woodcock on User Fees and Future of FDA Knowledge Management Read More
Advocacy at a Glance STEVEN GROSSMAN 7/29/22 Advocacy at a Glance STEVEN GROSSMAN 7/29/22 FY 23 Appropriations Update; User-fee Lay-off Risk; Woodcock Webinar Announcement Read More
Advocacy at a Glance STEVEN GROSSMAN 7/22/22 Advocacy at a Glance STEVEN GROSSMAN 7/22/22 Woodcock Webinar; FY23 Appropriations Minibus; and FDA Food Safety Programs face Congress and Independent Review Read More
Advocacy at a Glance STEVEN GROSSMAN 7/15/22 Advocacy at a Glance STEVEN GROSSMAN 7/15/22 Ag/FDA FY23 Approps Update, User Fee Reauthorization Uncertainty, and Dr. Woodcock Webinar Announcement Read More
Advocacy at a Glance STEVEN GROSSMAN 7/8/22 Advocacy at a Glance STEVEN GROSSMAN 7/8/22 House and Senate Calendar Updates; Understaffed FDA Offices; Inspections Updates Read More
Advocacy at a Glance Lisa Ellington 6/24/22 Advocacy at a Glance Lisa Ellington 6/24/22 Commissioner Califf to Address Alliance for a Stronger FDA: July 12 from 1:30 to 2:30. Read More
Advocacy at a Glance Lisa Ellington 6/17/22 Advocacy at a Glance Lisa Ellington 6/17/22 House Subcommittee Includes 10% Increase For FDA Read More
